A reduced SIRT3 content has been shown to increase insulin resistance (Lantier et al., 2015) and impair glucose oxidation by inhibition of PDH in favor of fatty acid utilization in skeletal muscle (Jing et al., 2013). This evidence concerns the gene SIRT3 and Insulin resistance.